Farmak expands its range of drugs for treatment of acute (stroke) and chronic cerebrovascular disorders – Lira (citicoline). The Company's experts have developed and launched Lira as 30 ml syrup.
Farmak is actively working towards the treatment of cardiovascular and cerebrovascular diseases. In particular, it focuses on ensuring full-scale provision of proper quality and affordable treatment of acute and chronic cerebral circulation disorders in adults, and neurological diseases in children. To that end, the Company's experts have developed and launched the medicinal product Lira as 30 ml syrup.
The medicinal product is prescribed to adult patients in the acuity period and on the following states:
Lira Syrup can also be used to treat muscle hypertonia of the lower extremities in children, encephalopathy, infantile cerebral paralysis (ICP), traumatic brain injury, effects of neuroinfections, and ischemic conditions during prenatal development.
The course of treatment is at least 45 days.
The Australian market is considered well-regulated – at the same level as the US and the EU. Therefore, only few Ukrainian companies have the opportunity to supply their products to this country. The share of sales to Australia and Oceania in Ukrainian exports of pharmaceutical products is only 0.3%. “Today, Farmak is about the only […]
Every year, on the 2nd Thursday of November, many countries celebrate the World Quality Day. It was first held in 1990 at the initiative of the European Organization for Quality (an independent non-profit association that brings together 40 national quality organizations in European countries) with the support of the United Nations. Subsequently, the week th...
The 6th Conference of Farmak School of Young Scientists was held on 1 November 2018. 130 guests and employees of Farmak JSC attended the event; 26 reports were presented. This conference already enjoys popularity among students, young scientists, and post-graduate students. The School of Young Scientists is a platform for presenting scientific achievements a...